Viewing Study NCT01333358


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-03-06 @ 2:31 PM
Study NCT ID: NCT01333358
Status: UNKNOWN
Last Update Posted: 2011-04-25
First Post: 2011-04-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients
Sponsor: Central Texas Neurology Consultants
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module